Idelalisib is a chemical compound widely used in pharmaceutical research and biochemical studies, particularly in the development of treatments for autoimmune diseases and cancer. As a kinase modulator, it plays a crucial role in inhibiting intracellular signaling pathways involved in cell proliferation and inflammation. This makes it an essential tool for researchers aiming to understand and manipulate cellular processes. In the laboratory, Idelalisib is frequently employed as a reagent in experiments focused on drug mechanism studies and therapeutic efficacy testing. Its versatility supports a broad range of experimental approaches, making it a valuable asset in modern research environments.
Idelalisib is known for its chemical stability and solubility in organic solvents such as ethyl acetate or acetone, which enhances its usability in various analytical and synthetic methods. Its thermal stability ensures long-term storage without significant degradation, maintaining consistency in experimental results. These properties make it a preferred choice for researchers requiring reliable and reproducible outcomes. The compound's predictable behavior under different conditions also contributes to its reliability in both academic and industrial research settings.
In Indonesian laboratories, Idelalisib is commonly used by researchers in universities and research centers to explore disease mechanisms and develop new therapeutic strategies. Its application spans multiple disciplines, including pharmacology, immunology, and oncology. The compound's availability and performance in experimental settings make it a key component in advancing scientific knowledge and innovation within the Indonesian scientific community.
- Pharmaceutical research for developing treatments targeting autoimmune disorders and malignancies due to its kinase modulating properties.
- Biochemical studies to investigate intracellular signaling pathways involved in cell proliferation and inflammatory responses.
- Drug mechanism studies to understand how therapeutic agents interact with cellular targets and influence biological processes.
- Therapeutic efficacy testing to evaluate the effectiveness of potential drugs in inhibiting disease-related pathways.
- Analytical and synthetic experiments requiring stable and soluble compounds for chemical analysis and compound synthesis.
| Brand | TCI |
|---|---|
| CAS number | 870281-82-6 |
| Molecular formula | — |
| Purity | — |
| Category | Life Science > Biochemicals and Reagents > Pharmaceutical Research Reagents |
| Pack sizes | Available in various quantities as per standard reagent packaging |
| Physical form | Solid powder |
| Storage | Store in a cool, dry place away from direct light |
Idelalisib should be stored in a cool, dry environment, away from direct sunlight and moisture to maintain its chemical stability. It is recommended to use airtight containers to prevent exposure to air and contaminants. Due to its solubility in organic solvents, it should be handled in a well-ventilated area to minimize inhalation risks. Researchers should wear appropriate personal protective equipment, including gloves and safety goggles, when handling the compound. Proper disposal procedures should be followed to ensure compliance with laboratory safety standards and environmental regulations. Regular inspection of storage conditions is advised to ensure the integrity of the compound remains unaffected over time.
—
Product Categories
- Biochemicals and ReagentsPharmaceutical Research Reagents (for Experimental Use)Antitumor Research Reagents (for Experimental Use)
- Biochemicals and Reagents
- Cell BiologyApoptosisApoptosis Inducers
- Cell BiologyCell Signaling and NeuroscienceKinase/Phosphatase Biology
- Pharmaceutical Development and Drug Discovery ResearchPharmaceutical Research Reagents (for Experimental Use)Antitumor Research Reagents (for Experimental Use)
